Evidence map›Paper›PMID 34189226›Full record

ArticleJAAD case reports2021

Erythema nodosum-like panniculitis associated with immune checkpoint inhibitor therapy: Two cases reporting a rare cutaneous adverse event.

Jolanta Pach, Katherine Moody, Nan Ring, Gauri Panse, Michael Zhang, Sandhya Deverapalli, Jonathan Leventhal

Open access · goldAbstract readCase Reports
In one paragraph

Article in JAAD case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Skin Manifestation Induced by Immune Checkpoint Inhibitors.Clinical, cosmetic and investigational dermatology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jolanta PachDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Katherine MoodyDepartment of Dermatology, Tufts University School of Medicine, Boston, Massachusetts.
Nan RingDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Gauri PanseDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Michael ZhangInform Diagnostics, Needham, Massachusetts.
Sandhya DeverapalliDepartment of Dermatology, Tufts University School of Medicine, Boston, Massachusetts.
Jonathan LeventhalDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Yale University · USTufts University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EN, erythema nodosumerythema nodosumICPi, immune checkpoint inhibitorimmune checkpoint inhibitorsimmune-related adverse eventpanniculitis

Identifiers

PMID34189226
PMCPMC8220292
OpenAlexW3172777676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.